PD-1-IN-20
PD-1-IN-20 is the less active enantiomer of PD-1-IN-1. PD-1-IN-1 is an inhibitor of programmed cell dealth-1 (PD-1) extracted from patent WO 2015033299 A1, compound example 4[1].
Product Specifications
UNSPSC
12352005
Target
PD-1/PD-L1
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pd-1-in-20.html
Solubility
10 mM in DMSO
Smiles
N[C@H](CO)C1=NOC([C@@H](NC(N[C@H](C(O)=O)[C@H](C)O)=O)CC(N)=O)=N1
Molecular Formula
C12H20N6O7
Molecular Weight
360.32
References & Citations
[1]Pottayil Govindan Nair Sasikumar, et al. Dérivés 1,2,4-oxadiazole utilisés comme immunomodulateurs. WO2015033299A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6461474-01 0.1 mL
ADAM 17, CT (A Disintegrin And Metalloproteinase 17, TNF-a Converting Enzyme, TACE, TNF alpha Converting Enzyme, CD156b) (MaxLight 650)
Sign In for Pricing
View Details MBS6461474-02 5x 0.1 mL
ADAM 17, CT (A Disintegrin And Metalloproteinase 17, TNF-a Converting Enzyme, TACE, TNF alpha Converting Enzyme, CD156b) (MaxLight 650)
Sign In for Pricing
View Details